A new procedure to induce aortic aneurysms in mice

Methods Cell Biol. 2024:188:61-71. doi: 10.1016/bs.mcb.2024.03.005. Epub 2024 May 31.


Aortic aneurysms (AAs) are a major public health challenge, featured by a progressive impairs in aortic wall integrity that drives to aortic dilation and, in end stage, to its rupture. Despite important advances in the surgical treatment of aortic aneurysms, there is currently no pharmacological intervention that prevents their development, reduces their expansion, or avoids their rupture. In addition to classic risk factors such age or gender, several heritable connective tissue disorders have been associated with AA developing, highlighting the role of extracellular matrix (ECM) genes alterations in the developing of AA. In this sense, we have recently demonstrated that global deletion of the cellular communicating network factor 2 (CCN2), previously known as connective tissue growth factor (CTGF) due to its role in the extracellular matrix formation, predisposes to early and lethal AAs development after Angiotensin II (Ang II) infusion in mice. Here, we detail the protocol to induce and detect AAs generation in inducible global CCN2 knockout mice after Ang II infusion which allow the characterization of CCN role in AA development and may help to the development of pharmacological target for AA treatment.

Keywords: Angiotensin II; Aortic aneurysm; CCN2 knockout.

MeSH terms

  • Angiotensin II* / metabolism
  • Angiotensin II* / pharmacology
  • Animals
  • Aortic Aneurysm* / etiology
  • Aortic Aneurysm* / genetics
  • Aortic Aneurysm* / metabolism
  • Aortic Aneurysm* / pathology
  • Connective Tissue Growth Factor* / genetics
  • Connective Tissue Growth Factor* / metabolism
  • Disease Models, Animal*
  • Mice
  • Mice, Knockout*


  • Connective Tissue Growth Factor
  • Angiotensin II
  • CCN2 protein, mouse